Actively Recruiting
Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery
Led by The First Affiliated Hospital of Guangzhou Medical University · Updated on 2024-02-29
20
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Robotic surgical systems have become a promising surgical assistance system, with unique advantages such as 3D high-definition visual system, highly flexible wrist-jointed instruments, and automatic fitering of hand tremors. Robotic surgical systems is applied in various fields including urology, general surgery, cardiothoracic surgery, head and neck surgery, and gynecology. Currently, the Da Vinci surgical robot system is the most widely used robot system globally. However, the Da Vinci robot system for single-port laparoscopic surgery has not yet been launched in China. Therefore, the investigators conduct a prespective, single-center study to evaluate the efficacy and safety of single-port surgical robot system in thoracic surgery.
CONDITIONS
Official Title
Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years, regardless of gender.
- Patients who require endoscopic surgical treatment and have indications for lung segment or lobe resection.
- For pre-trial subjects, inclusion based on investigator's judgment of thoracic surgery indication.
- Preoperative ASA classification of I-III.
- Voluntary participation with informed consent by subject or guardian.
- Willingness to cooperate and complete trial follow-up and related examinations.
You will not qualify if you...
- History of thoracic surgery or other malignant tumors unsuitable for inclusion.
- Severe comorbidities preventing general anesthesia or surgery.
- Severe bleeding tendencies or coagulation disorders.
- Active infectious diseases or severe non-communicable infections.
- Positive for HIV antibodies or syphilis seropositive.
- Suspected or confirmed addiction to alcohol, drugs, or substances.
- History of epilepsy, mental illness, or cognitive impairment.
- Women who are pregnant, breastfeeding, or planning pregnancy during the trial.
- Participation in other interventional clinical trials within 3 months before consent.
- Other situations deemed inappropriate by investigator for participation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510000
Actively Recruiting
Research Team
J
Jianxing He, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here